FDG-PET/CT in the staging of local/regional metastases in breast cancer

被引:53
|
作者
Robertson, Ian J. [1 ]
Hand, Fiona [1 ]
Kell, Malcolm R. [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
来源
BREAST | 2011年 / 20卷 / 06期
关键词
FDG-PET/CT; Breast cancer; Local/regional metastases; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE BIOPSY; MANAGEMENT; SCAN;
D O I
10.1016/j.breast.2011.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the commonest female malignancy in the Western world and the most reliable predictor for survival is axillary lymph node metastases. Conventional staging techniques employed in breast cancer include mammography, ultrasonography, isotope bone scanning, sentinel lymph node biopsy, axillary lymph node dissection and magnetic resonance imaging. More recently FDG-PET and FDG-PET/CT have been used to complement the above methods. This review assesses the role of FOG-PET/CT in axillary staging ill patients with primary breast cancer. A PubMed search was conducted and all articles containing relevant or new information were included. Relevant studies examined identified that FOG-PET/CT has a sensitivity of 60% and a specificity of 97% in detecting lymphatic metastasis. Although positive axillary FOG-PET/CT is a good predictor of axillary disease and correlates well with SLNB, the relatively poor sensitivity (60%) must be considered for treatment planning. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 50 条
  • [1] FDG-PET and PET/CT in breast cancer staging
    Avril, Norbert
    Mather, Stephen J.
    Roylance, Rebecca
    [J]. BREAST CARE, 2007, 2 (06) : 372 - 377
  • [2] FDG-PET/CT staging in inflammatory breast cancer
    Peller, P. J.
    Subramaniam, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S247 - S247
  • [3] Integrated FDG-PET/CT for initial staging of breast cancer
    Khan, Q. J.
    O'Dea, A. P.
    Dusing, R.
    Sharma, P.
    Roling, S. M.
    Fabian, C. J.
    Kimler, B. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer
    Groheux, David
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (05) : 508 - 519
  • [5] Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer
    Orsaria, Paolo
    Chiaravalloti, Agostino
    Caredda, Emanuele
    Marchese, Paola Valeria
    Titka, Brisida
    Anemona, Lucia
    Portarena, Ilaria
    Schillaci, Orazio
    Petrella, Giuseppe
    Palombi, Leonardo
    Buonomo, Oreste Claudio
    [J]. ANTICANCER RESEARCH, 2018, 38 (12) : 6639 - 6652
  • [6] FDG PET FOR THE LOCAL-REGIONAL STAGING OF BREAST-CANCER
    ADLER, LP
    SHANK, RR
    SCHNUR, KC
    [J]. RADIOLOGY, 1995, 197 : 352 - 353
  • [7] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    Groheux, David
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1417 - 1419
  • [8] The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer
    Paydary, Koosha
    Seraj, Siavash Mehdizadeh
    Zadeh, Mahdi Zirakchian
    Emamzadehfard, Sahra
    Shamchi, Sara Pourhassan
    Gholami, Saeid
    Werner, Thomas J.
    Alavi, Abass
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (01) : 1 - 10
  • [9] FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
    David Groheux
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1417 - 1419
  • [10] Variation in the use of FDG-PET/CT in staging of node positive breast cancer
    Veneklaas, L.
    De Geus-Oei, L. F.
    Verloop, J.
    Klaase, J.
    Ticheler, C.
    Bavelaar-Croon, C.
    Siesling, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S145 - S145